Marshall Wace LLP reduced its holdings in shares of Nuvectis Pharma, Inc. (NASDAQ:NVCT – Free Report) by 32.4% in the second quarter, according to its most recent Form 13F filing with the Securities ...

Apart from mistrust in the larger pharmaceutical world and Pfizer's inability to find a major break after the pandemic ...

Code Pharma, a pioneering pharmaceutical company headquartered in the Netherlands, is set to present groundbreaking findings from its clinical trials on GAMMORA, a drug aimed at treating HIV, at two ...

A skincare academy in Seoul is attracting a diverse group of international students eager to learn K-beauty techniques. On ...

Recent health news highlights include HIV transmission via organ transplants in Brazil, Sanofi discussing a sale of its ...

On Friday, Vincerx Pharma Inc (VINC) stock saw a modest uptick, ending the day at $0.39 which represents no change from the prior close of of $0.39. The stock opened at $0.39 and touched a low of ...

Al-Madina Pharmaceuticals, a publicly listed firm on the SME platform, has proposed a 12% cash dividend exclusively for its general shareholders, excluding sponsor-directors, despite a 44% decline in ...

On Friday, Urogen Pharma Ltd (URGN) stock saw a modest uptick, ending the day at $12.6 which represents a slight increase of $0.69 or 5.79% from the prior close of $11.91. The stock opened at $11.82 ...

We came across a bullish thesis on Tempus AI, Inc (TEM) on Two Natural Cap’s Substack by Two Natural Capital. In this article ...

With that in mind, let's examine two pharma stocks that are incredibly cheap and which are worth buying right now, assuming ...

If Medicare were to start covering popular weight loss drugs such as Wegovy and Zepbound, it could increase federal spending ...

Marshall Wace LLP raised its position in Vincerx Pharma, Inc. (NASDAQ:VINC – Free Report) by 359.1% during the second quarter, according to the company in its most recent 13F filing with the ...